Arbutus Biopharma
ABUS
#7158
Rank
NZ$1.13 B
Marketcap
NZ$7.40
Share price
1.49%
Change (1 day)
-7.43%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2026 (TTM): NZ$0.26 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are NZ$0.18 Billion. In 2025 the company made an earning of -NZ$60.6 Million, an increase over its 2024 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.26 B-538.81%
2025 -NZ$60.6 Million-52.09%
2024 -NZ$0.13 Billion-4.02%
2023 -NZ$0.14 Billion12.05%
2022 -NZ$0.12 Billion-14.74%
2021 -NZ$0.14 Billion19.61%
2020 -NZ$0.12 Billion-61.69%
2019 -NZ$0.31 Billion171.23%
2018 -NZ$0.12 Billion-43.58%
2017 -NZ$0.2 Billion-77.77%
2016 -NZ$0.89 Billion532.77%
2015 -NZ$0.14 Billion99.05%
2014 -NZ$70.25 Million175.82%
2013 -NZ$25.47 Million-143.7%
2012 NZ$58.28 M-399.11%
2011 -NZ$19.49 Million-39.03%
2010 -NZ$31.97 Million100.55%
2009 -NZ$15.94 Million-28.56%
2008 -NZ$22.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.91 Million-101.41% Bahamas
NRC Health
NRC
NZ$26.75 M-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA